Acumen Hypotension Prediction Index (HPI) Feature Software vs Ligence Heart

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

Ligence Heart

by Ligence

AI Verdict

Tool A, Acumen HPI, is designed for real-time prediction and proactive management of hypotensive events using physiological monitoring data, primarily in critical care and surgical environments. Tool B, Ligence Heart, focuses on automating the analysis and reporting of echocardiography images to enhance diagnostic efficiency for cardiologists. While both fall under the broad category of 'Cardiology AI', they address distinct clinical problems and workflows, making them adjacent rather than direct competitors.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) if your primary goal is proactive prevention and real-time management of hypotensive events in critically ill or surgical patients. This tool is ideal for settings like the OR or ICU where continuous hemodynamic monitoring and early intervention are crucial to improve patient outcomes by predicting hypotension up to 15 minutes in advance.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Ligence Heart if…

Choose Ligence Heart if your cardiology department seeks to significantly enhance the efficiency and standardization of 2D transthoracic echocardiography analysis and reporting. This AI-powered platform is best suited for automating complex measurements, classifying views, and generating comprehensive reports, thereby streamlining workflow and improving diagnostic accuracy for a high volume of echo studies.

View Ligence Heart →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Pricing	Unknown	Contact-for-pricing
Deployment	Unknown	Cloud-based; on-premise; hybrid
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart (Tool B) is a web-based platform with flexible deployment options (cloud, on-premise, hybrid) and an intuitive interface designed to automate complex echocardiography analysis and report generation, making it broadly accessible and easy to adopt for cardiologists and sonographers. Acumen HPI (Tool A) is integrated into a specific proprietary monitoring platform, which, while streamlined for its ecosystem, may limit its general usability and accessibility for users outside of that specific hardware environment.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI (Tool A) offers a direct and quantifiable clinical benefit by demonstrating a reduction in the incidence, duration, and severity of intraoperative hypotension, a critical patient safety concern. It provides proactive insights up to 15 minutes before an event, enabling timely intervention. Ligence Heart (Tool B) enhances diagnostic efficiency and accuracy for echocardiography, which is valuable for patient management, but Tool A's impact on preventing acute, life-threatening events is more immediate and directly measurable in terms of patient outcomes.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact with the vendor for quotes and details. Without publicly available pricing information for either product, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value for money.

Enterprise Readiness

Ligence Heart

Ligence Heart (Tool B) offers flexible deployment options (cloud, on-premise, hybrid) and explicitly states integration capabilities with existing hospital systems like PACS, EHR, and RIS, which are crucial for seamless enterprise adoption. While Acumen HPI (Tool A) has FDA clearance, BAA, and HIPAA compliance, its deployment is integrated into a specific proprietary platform, which might pose challenges for enterprises not fully invested in that ecosystem.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI (Tool A) is described as a 'first-of-its-kind technology' that uses machine learning to predict hypotensive events up to 15 minutes in advance, enabling proactive intervention for a critical physiological instability. This predictive capability for a life-threatening event represents a significant advancement in real-time patient management. Ligence Heart (Tool B) also offers innovative AI-powered automation for echocardiography analysis, but Tool A's direct predictive intervention for a critical event gives it a slight edge in groundbreaking innovation.

Support & Docs

Tie

Both Edwards Lifesciences and Ligence, as providers of FDA-cleared medical devices, are expected to offer comprehensive support and documentation. Edwards Lifesciences provides technical support and educational resources for its HemoSphere platform, which includes Acumen HPI. Ligence provides Instructions for Use (IFU), software installation manuals, training videos, and customer service contacts for technical support. However, without specific comparative details on the scope, availability, or quality of their support offerings, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Tool Name	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Company	Edwards Lifesciences	Ligence
Primary Function	Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs.	AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography.
Primary Specialties	Anesthesiology, Critical Care, Emergency Medicine	Cardiology
Core AI/ML Use Case	Predictive analysis of blood pressure waveforms for impending hypotensive events.	Automated recognition of echocardiography imaging data, view classification, and heart phase prediction.
Key Output/Result	Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts, Relationship View screen.	Automated calculation of measurements, report generation, disease recognition.

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Ligence Heart.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools specifically enhance clinical decision-making and patient outcomes within their intended specialties?

Acumen HPI provides a predictive score and alerts for impending hypotensive events, allowing clinicians in Anesthesiology, Critical Care, and Emergency Medicine to proactively manage hemodynamics and potentially reduce the incidence, duration, and severity of intraoperative hypotension. Ligence Heart automates the analysis and reporting of 2D transthoracic echocardiography, improving diagnostic efficiency and accuracy for cardiologists and sonographers by providing automated measurements and disease recognition for conditions like heart failure and valvular diseases.

How do these tools integrate into existing clinical workflows and what is the depth of their EHR integration?

Acumen HPI is integrated into the Edwards Lifesciences HemoSphere advanced monitoring platform, providing real-time predictive insights within that ecosystem. The provided facts do not specify direct EHR integration for data export beyond this platform. Ligence Heart is designed for integration with existing systems such as PACS, EHR, and RIS, automating the transfer of echocardiography images (with PHI removed) for analysis and report generation, thereby streamlining the diagnostic workflow.

What is the basis for the accuracy and reliability of the predictive or analytical capabilities of each tool?

Acumen HPI uses machine learning algorithms to analyze blood pressure waveforms and predict hypotension up to 15 minutes before an event, with demonstrated reductions in the incidence, duration, and severity of intraoperative hypotension. Ligence Heart enhances diagnostic efficiency and accuracy through automated recognition of echocardiography imaging data, view classification, heart phase prediction, and precise automated calculations for various measurements including Area, Distance, Doppler, Volume, Strain, Spectral, and Tissue Doppler.

What is the expected learning curve for physicians and clinical staff to become proficient in using these tools?

While not explicitly stated, Acumen HPI's integration into the HemoSphere platform and its presentation of a clear HPI score, Smart Alerts, and specific screens suggest a structured interface that may facilitate adoption for users already familiar with the monitoring system. Ligence Heart automates complex tasks like image recognition, measurement calculation, and report generation, which could potentially reduce the manual effort and associated learning curve for these specific echocardiography analysis processes, with training videos provided to operators.

What considerations should be taken into account for deploying these tools across multiple clinical sites?

Acumen HPI's deployment is integrated into the Edwards Lifesciences HemoSphere platform, implying that multi-site rollout would likely align with the existing HemoSphere infrastructure and support model. Ligence Heart's ability to transfer echocardiography images (with PHI removed) from hospital PACS and its integration with existing systems (PACS, EHR, RIS) suggests a design that can accommodate data flow from various sources, which is beneficial for multi-site deployments.